Best Ovarian Cancer Screening Services - Early Detection Tests

Ovarian cancer is among the most challenging cancers to detect early, as symptoms like persistent bloating, abdominal pain, or frequent urination are often vague and mistaken for less serious conditions. Because of this, ovarian cancer screening has become an important preventive measure, particularly for women with higher risk factors.

Overview of Common Screening Tests

The most common screening tests for ovarian cancer are transvaginal ultrasound (TVUS) and the CA-125 blood test. These screening tools help identify abnormalities but are more effective when combined with genetic risk evaluation. Meanwhile, continuing medical research is exploring a new screening test for ovarian cancer that may improve outcomes, though population-wide screening guidelines are still under careful study worldwide.

Types of Ovarian Cancer Screening

Transvaginal Ultrasound (TVUS)

TVUS is one of the most widely recommended imaging options for ovarian cancer testing and screening. It uses high-frequency sound waves to produce images of the ovaries, fallopian tubes, and uterus, helping identify cysts, tumors, or abnormalities. While TVUS alone cannot confirm cancer, it plays a valuable role in ongoing follow-up for women at elevated risk.

CA-125 Blood Test

CA-125 is a protein that tends to be present in higher levels in women with ovarian cancer. Although it is not a very specific test, levels can rise in benign conditions like endometriosis or pelvic infections; it remains one of the most widely used screening tests for ovarian cancer. In high-risk women, it is often performed alongside TVUS to increase sensitivity and minimize missed diagnoses.

Ovarian MRI – High-Tech Imaging for High-Risk Cases

Magnetic Resonance Imaging (MRI) is sometimes recommended if an ultrasound results are suspicious or if a patient has significant family history or genetic predisposition. MRI provides detailed cross-sectional images that allow doctors to examine suspicious ovarian growths closely. Though not a mass-screening tool, MRI is an advanced option within ovarian cancer testing and screening for high-risk women.

Clinical Ovarian Examination & Symptom Awareness

Pelvic examinations are not sufficient standalone methods to detect ovarian cancer, but they can reveal ovarian enlargement or tenderness. Unlike breast cancer, there is no practical self-check method for ovarian cancer. Still, awareness of common recurring symptoms such as bloating lasting more than two weeks, changes in appetite, or increased urinary urgency (remains an essential part of preventive care and early medical evaluation).

Ovarian Cancer Screening Procedure

Scheduling and Pre-Appointment Guidelines

At Everhope, it is simple to schedule ovarian cancer screening either online or by phone. Patients may be given pre-appointment guidelines, including advice to maintain an empty bladder or provide a comprehensive family history, which assists in risk assessment.

What Happens During the Screening Process

• •Gynecology consultation
  To record detailed medical and genetic history
• •Imaging tests
  Such as transvaginal ultrasound
• •Blood samples
  For the CA-125 test
• •Advanced imaging or referral
  For genetic testing if required

The procedure is typically non-invasive, painless, and can be completed during a single clinic visit.

How and When You’ll Receive Results

At Everhope, most results are available within 24 to 48 hours, depending on the scope of ovarian cancer testing and screening conducted. Any abnormal findings are promptly reviewed with the patient, and if needed, confirmatory diagnostic tests such as biopsy or PET-CT scans may be advised.

Get Your Free Cancer Diet Plan & Report Analysis Now on WhatsApp

Talk to experts. Understand your reports. Get a personalized diet plan — all free to start.

Get My Free Plan on WhatsApp

India's First Cancer Care Management Platform

Free to start•Secure & private•No app download needed

Ovarian Cancer Screening Guidelines & Recommended Frequency

How Often Should You Get Screened?

For women at average risk, universal screening is not yet recommended. However, for women with family history, genetic mutations, or other significant risk factors, ongoing surveillance can prove lifesaving.

Changing Frequency of Screening According to Risk

• •Average-risk women
  Annual gynecological visits, with detailed symptom awareness. Routine structured screening is not required.
• •High-risk women (BRCA1/2 or Lynch syndrome carriers)
  A combination of TVUS and CA-125 every 6 to 12 months beginning between age 30–35, or earlier if family risk is strong.
• •Postmenopausal women
  More intensive monitoring is required, as the ovarian cancer age of diagnosis most commonly falls between 50 and 65.

Identifying High-Risk Groups for Cancer Screening

Genetic and Family History Factors

Inherited genetic mutations play one of the most critical roles in ovarian cancer risk. Women carrying BRCA1, BRCA2, or Lynch syndrome mutations have significantly higher lifetime risk. For these patients, screening tests for ovarian cancer are strongly advised as part of ongoing surveillance.

Lifestyle and Environmental Risk Factors

Lifestyle factors such as obesity, long-term hormone replacement therapy, and tobacco use also elevate ovarian cancer risks. Identifying these patients early allows healthcare teams to recommend more personalized screening schedules.

Screening Guidelines for Younger and Older Women

• •Younger Women (<40 years)
  Generally, screening is unnecessary unless there is a proven genetic or family risk. Rare germ cell tumors can arise in young women, and in such cases, screening and monitoring are critical.
• •Older Women (50+ years)
  Since most ovarian cancer cases occur in postmenopausal women, consistent monitoring and awareness of symptoms are especially important in this group.

Why Choose Everhope for Cancer Screening

Expert and Experienced Medical Staff

Our multidisciplinary team—oncologists, gynecologists, radiologists, and genetic counselors—bring advanced expertise backed by years of experience in diagnosing and screening women’s cancers.

State-of-the-Art Imaging Technology and Equipment

We adopt the latest ultrasound, MRI, and diagnostic systems, offering our patients accurate results and minimizing delays. Everhope also follows international research updates to integrate any validated new screening test for ovarian cancer as they become available.

Personalised Care and Patient Comfort

Every patient at Everhope receives personalized care. From risk assessment to empathetic communication, we prioritize comfort, confidentiality, and emotional support throughout your ovarian cancer screening journey.